Conference Report: ‘Psychiatric Genomics Consortium meeting: Pathways to Drugs’ London, March 2017

The Psychiatric Genomics Consortium (PGC; https://pgc.www.med.unc.edu/pgc) is delivering an increasing flow of discoveries about the fundamental basis of psychiatric disorders. Moving from discovery of GWAS loci towards delivering new therapeutic approaches is a challenge which requires a new wave of multidisciplinary work and close liaison between academia and industry. The PGC has recently initiated a new research program to deliver “actionable” findings that (a) reveal the fundamental biology of psychiatric disorders, (b) inform clinical practice, and (c) deliver new therapeutic targets.

Source: Biological Psychiatry - February 8, 2018 Category: Psychiatry Authors: H éléna A. Gaspar, David A. Collier, Daniel H. Geschwind, Cathryn M. Lewis, Qingqin Li, Bryan Roth, Patrick Sullivan, Gerome Breen Tags: Correspondence Source Type: research